BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Müller-Fielitz H, Markert A, Wittmershaus C, Pahlke F, Jöhren O, Raasch W. Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure. Naunyn Schmiedebergs Arch Pharmacol 2011;383:373-84. [PMID: 21287150 DOI: 10.1007/s00210-011-0602-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen MJ, Wei YJ, Dong XX, Liu JY, Chen QY, Zhang GX. The effect of candesartan on chronic stress induced imbalance of glucose homeostasis. Biomed Pharmacother 2020;128:110300. [PMID: 32485572 DOI: 10.1016/j.biopha.2020.110300] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Gustaityte V, Winkler M, Stölting I, Raasch W. Influence of AT1 blockers on obesity and stress-induced eating of cafeteria diet. Journal of Endocrinology 2019;240:65-79. [DOI: 10.1530/joe-18-0477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Michel MC, Brunner HR, Foster C, Huo Y. Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease. Pharmacol Ther 2016;164:1-81. [PMID: 27130806 DOI: 10.1016/j.pharmthera.2016.03.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
4 Müller-Fielitz H, Hübel N, Mildner M, Vogt FM, Barkhausen J, Raasch W. Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats. Br J Pharmacol 2014;171:746-60. [PMID: 24490862 DOI: 10.1111/bph.12510] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
5 Schuchard J, Winkler M, Stölting I, Schuster F, Vogt FM, Barkhausen J, Thorns C, Santos RA, Bader M, Raasch W. Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway. Br J Pharmacol 2015;172:3764-78. [PMID: 25906670 DOI: 10.1111/bph.13172] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
6 Dapper C, Schuster F, Stölting I, Vogt F, Castro e Souza LA, Alenina N, Bader M, Raasch W. The antiobese effect of AT1 receptor blockade is augmented in mice lacking Mas. Naunyn-Schmiedeberg's Arch Pharmacol 2019;392:865-77. [DOI: 10.1007/s00210-019-01643-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Moreau J, Messenger S, Ciriello J. Effects of angiotensin II on leptin and downstream leptin signaling in the carotid body during acute intermittent hypoxia. Neuroscience 2015;310:430-41. [DOI: 10.1016/j.neuroscience.2015.09.066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Müller-Fielitz H, Lau M, Geißler C, Werner L, Winkler M, Raasch W. Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats. Br J Pharmacol 2015;172:857-68. [PMID: 25258168 DOI: 10.1111/bph.12949] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
9 Winkler M, Schuchard J, Stölting I, Vogt FM, Barkhausen J, Thorns C, Bader M, Raasch W. The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats. Br J Pharmacol 2016;173:1602-17. [PMID: 26892671 DOI: 10.1111/bph.13461] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
10 Huber G, Ogrodnik M, Wenzel J, Stölting I, Huber L, Will O, Peschke E, Matschl U, Hövener JB, Schwaninger M, Jurk D, Raasch W. Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior. J Cereb Blood Flow Metab 2021;41:2356-69. [PMID: 33730932 DOI: 10.1177/0271678X211003497] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Walton SL, Mazzuca MQ, Tare M, Parkington HC, Wlodek ME, Moritz KM, Gallo LA. Angiotensin receptor blockade in juvenile male rat offspring: Implications for long-term cardio-renal health. Pharmacol Res 2018;134:320-31. [PMID: 29870806 DOI: 10.1016/j.phrs.2018.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Miesel A, Müller-Fielitz H, Jöhren O, Vogt FM, Raasch W. Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats. Br J Pharmacol 2012;165:2721-35. [PMID: 22014027 DOI: 10.1111/j.1476-5381.2011.01726.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
13 Rodriguez R, Minas JN, Vazquez-Medina JP, Nakano D, Parkes DG, Nishiyama A, Ortiz RM. Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats. J Endocrinol 2018;237:271-84. [PMID: 29643115 DOI: 10.1530/JOE-17-0678] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Mildner M, Müller-fielitz H, Stölting I, Jöhren O, Steckelings M, Raasch W. Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism. Naunyn-Schmiedeberg's Arch Pharmacol 2017;390:505-18. [DOI: 10.1007/s00210-017-1346-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Schuster F, Huber G, Stölting I, Wing EE, Saar K, Hübner N, Banks WA, Raasch W. Telmisartan prevents diet-induced obesity and preserves leptin transport across the blood-brain barrier in high-fat diet-fed mice. Pflugers Arch 2018;470:1673-89. [PMID: 29978352 DOI: 10.1007/s00424-018-2178-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
16 Müller-fielitz H, Landolt J, Heidbreder M, Werth S, Vogt FM, Jöhren O, Raasch W. Improved Insulin Sensitivity after Long-Term Treatment with AT1 Blockers Is Not Associated with PPARγ Target Gene Regulation. Endocrinology 2012;153:1103-15. [DOI: 10.1210/en.2011-0183] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
17 Beckmann L, Künstner A, Freschi ML, Huber G, Stölting I, Ibrahim SM, Hirose M, Freitag M, Langan EA, Matschl U, Galuska CE, Fuchs B, Knobloch JK, Busch H, Raasch W. Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect. Pharmacol Res 2021;170:105724. [PMID: 34116209 DOI: 10.1016/j.phrs.2021.105724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Nickel L, Sünderhauf A, Rawish E, Stölting I, Derer S, Thorns C, Matschl U, Othman A, Sina C, Raasch W. The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice. Front Pharmacol 2022;13:815353. [DOI: 10.3389/fphar.2022.815353] [Reference Citation Analysis]
19 Cichello SA, Weisinger RS, Schuijers J, Jois M. 1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model. J Cachexia Sarcopenia Muscle 2014;5:239-46. [PMID: 24614996 DOI: 10.1007/s13539-014-0133-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
20 Marques MB, Ribeiro-oliveira A, Guimarães J, Nascimento GF, Anjos AP, Vilas-boas WW, Santos RAS, Thomas JD, Igreja SM, Grossman AB, Kola B, Korbonits M. Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker. Stress 2012;15:554-61. [DOI: 10.3109/10253890.2011.648673] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
21 Pechlivanova D, Krumova E, Kostadinova N, Mitreva-Staleva J, Grozdanov P, Stoynev A. Protective effects of losartan on some type 2 diabetes mellitus-induced complications in Wistar and spontaneously hypertensive rats. Metab Brain Dis 2020;35:527-38. [PMID: 31997264 DOI: 10.1007/s11011-020-00534-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]